| INTRODUC TI ON
Delayed graft function (DGF) after kidney transplantation is associated with decreased long-term graft survival, increased risk of infection, and healthcare-associated cost. [1] [2] [3] Previously identified risk factors for DGF include donor age and creatinine, cold ischemia time, donation after cardiac death, and recipient body mass index. Several definitions for DGF are used clinically: DGF can be defined either based on the need for hemodialysis within the first 7 days after transplant or by the change in postoperative creatinine clearance. increased central venous and pulmonary artery pressures and improved postoperative graft function. [4] [5] [6] Conversely, some report restrictive hydration regimens yield similar outcomes. 7 Central venous pressure monitoring requires the placement of a central venous catheter. Central venous catheters are associated with a risk of vascular injury, thrombosis, line infection, mechanical complications, and increased cost. 8, 9 Currently, there is no consensus on whether CVP monitoring is required for routine kidney transplantation.
The aim of this study was to compare intraoperative patient management and post-transplant graft function, as defined by the creatinine reduction ratio on post-transplant day 2 (CCR2), 10 an early surrogate of delayed graft function, in living donor kidney transplant recipients with and without perioperative CVP measurement.
| PATIENTS AND ME THODS
All patients undergoing living donor kidney transplantation at the Exclusion criteria were recipient age below 18 years and concomitant surgery such as removal of polycystic kidneys or combined liver and kidney transplantation. The study was approved by the institutional review board of the University of California, San Francisco.
| Graft recovery and surgical technique
Donor and recipient surgeries were performed simultaneously in 2 adjacent operating rooms to minimize cold ischemia time. All donor and recipient surgeries were performed locally at UCSF Medical
Center. All organs were recovered via our standardized laparoscopic donor nephrectomy procedure, from ASA class I or II living donors. Intraoperative management of living kidney donors follows strict guidelines and follows a standard protocol at our institution.
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All grafts were flushed with preservation solution (University of Wisconsin, DuPont Pharmaceuticals, Wilmington, DE, USA) and stored on ice until implantation. In the recipient, the arterial and venous anastomoses were performed in an end-to-side fashion to the external iliac artery and vein via a retroperitoneal approach, unless recipient anatomy required a modified approach. Cold ischemia time was less than 60 minutes in all cases during the study period.
| Intraoperative recipient management
As per our institutional kidney transplant anesthetic protocol, general anesthesia was induced with propofol, cisatracurium, small doses of fentanyl, and esmolol titrated to effect. Anesthesia was maintained with desflurane or sevoflurane, and fentanyl. Intraoperative muscle relaxation was maintained with cisatracurium. There are no dedicated anesthesiologists for kidney transplantation at our institution. The decision about whether or not to place a central line for CVP monitoring was left to the discretion of the anesthesiologist and surgeon.
Blood pressure monitoring was at the discretion of the anesthesiologist and in the vast majority monitored non-invasively. All patients received antibiotic prophylaxis against skin flora prior to incision and immunosuppressive induction according to our standard protocol.
During completion of the vascular anastomoses, 100 mg furosemide and 12.5 g of mannitol were infused over 30 minutes in all patients.
| Recipient characteristics and perioperative variables
The following data were extracted from the patients electronic Missing data: All effort was made to recover missing data from the electronic medical record. Height was not documented for thirteen patients in the dataset; the gender-specific median height for males was substituted; and BMI was calculated based on the patient's recorded weight. If a weight was not recorded (2 patients), the gender-specific median weight was used. Serum creatinine measurement at 3 months was not available for 18 patients; the creatinine measurement closest to 3 months was substituted (range: 0.5-6 months, median 2 months). Three patients were missing crystalloid administration volume; value was replaced with the median (3000 mL). Estimated blood loss was not recorded in 11 patients; the median blood loss (100 mL) was therefore assumed in these cases. Finally, warm ischemia time was unavailable for 3 patients in the CVP group and 21 in the control group; these values were not imputed as the variable was not used in multivariable modeling. Data are given as mean ± standard deviation, n (%), %, or median [IQR]. Significant P values are given in bold.
| Statistical analysis
Percentage for the propensity-matched weighted cohort is given as weighted %. monitored in 84 patients (29.0%). Patient demographics and baseline characteristics for the unadjusted cohort are given in Table 1 .
Intraoperative parameters such as operating time, ischemia time and volume administered, and estimated blood loss are shown in Table 2 .
In the unadjusted analysis, patients who underwent CVP monitoring were more likely to have had their operation early in the study period, to be on preoperative HD, to have a longer case duration, and to have a longer hospital length of stay. There was no difference in unadjusted CRR2 or the incidence of DGF ( Baseline characteristics were well-matched in the weighted cohort (Table 1) . There was no difference in case duration, CCR2, incidence of DGF, or hospital length of stay between the 2 groups (Table 2 ).
| D ISCUSS I ON
In this single-center analysis, there was no association between the use of CVP monitoring and immediate post-transplant renal function in recipients of living donor kidney transplants, in multivariableadjusted modeling of CRR2 and a propensity-matched cohort.
We used the CCR2 to compare post-transplant graft function between the 2 patient groups. The sensitivity of CCR2 to predict graft failure at 1 year is 100%. 3 A scaled outcome parameter allowed a more precise comparison of post-transplant kidney function between the 2 groups than the binary outcome of DGF.
There is no consensus whether CVP monitoring is beneficial and whether it should be considered as the standard of perioperative care in kidney transplant recipients. 4, 5 Aggressive hydration guided by CVP monitoring has been deemed essential for successful graft function and outcome. 13 In a previous study of 155 deceased donor graft recipients, a low CVP at the end of surgery and a restrictive fluid strategy were identified as risk factors for DGF. 6 The mean amount of fluid administered in that study was 2161 ± 727 mL in patients with and 2401 ± 792 mL in patients without DGF, respectively. In our study, the amount of fluid administered intraoperatively did not differ in between patients with and without CVP measurement. Interestingly, in the previously mentioned study, 6 both groups received less fluid than the patients in our study, where a median of 3L was administered regardless of CVP monitoring.
There is evidence that a CVP target of 5 mm Hg prior to and 15 mm Hg during the graft warm ischemia time may improve diuresis and increase hemodynamic stability compared to a constant infusion rate. 13 Although both groups in that study received the same amount of fluids, patients whose fluid balance was managed by CVP received more than twice the amount of fluid during the warm ischemia phase (2320 ± 658 mL and 840 ± 316 mL, respectively). The total amount of fluid administered in that study
(mean approximately 3000 mL) was comparable to our study (mean 3300 mL). Our findings are in line with recommendations from de Gasperi 7 that aggressive hydration might not be beneficial during kidney transplantation.
Central line insertions are associated with well-known complications. 9, 14, 15 The incidence of serious complications such as pneumothorax, hemothorax, and arterial puncture has been reported at 3.1% in a cohort of 487 catheter insertions. 9 Central lines might not be removed promptly after transplantation, and this can put the patient at risk of catheter-related blood stream infections and venous thromboembolic events. 15 Furthermore, in the kidney transplant population, central venous stenosis is a complication of long-term venous access such as hemodialysis catheters. 16 Avoiding central Performed the statistical analysis; and Dieter Adelmann, Claus U.
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